Elevated levels of the circulatory ischemia-modified albumin in patients with polycystic ovary syndrome: a meta-analysis

References

• March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010;25:544–51.
   PubMed Web of Science ®Google Scholar
• Barber TM, Dimitriadis GK, Andreou A, Franks S. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance. Clin Med (Lond) 2015;15:S72–S6.
   PubMedGoogle Scholar
• Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol 2011;335:30–41.
   PubMed Web of Science ®Google Scholar
• Cascella T, Palomba S, De Sio I, et al. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod 2008;23:153–9.
   PubMed Web of Science ®Google Scholar
• Zuo T, Zhu M, Xu W. Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers. Oxid Med Cell Longev 2016;2016:8589318.
   PubMed Web of Science ®Google Scholar
• Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol 2015;4:180–3.
   PubMed Web of Science ®Google Scholar
• Palacio JR, Iborra A, Ulcova-Gallova Z, et al. The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients. Clin Exp Immunol 2006;144:217–22.
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Rael LT, Bar-Or R, et al. The cobalt-albumin binding assay: insights into its mode of action. Clin Chim Acta 2008;387:120–7.
   PubMed Web of Science ®Google Scholar
• Ustün Y, Engin-Ustün Y, Oztürk O, et al. Ischemia-modified albumin as an oxidative stress marker in preeclampsia. J Matern Fetal Neonatal Med 2011;24:418–21.
   PubMed Web of Science ®Google Scholar
• Reddy SV, Suchitra MM, Pradeep V, et al. Ischemia-modified albumin levels in overt and subclinical hypothyroidism. J Endocrinol Invest 2015;38:885–90.
   PubMed Web of Science ®Google Scholar
• Ukinc K, Eminagaoglu S, Ersoz HO, et al. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine 2009;36:425–32.
   PubMed Web of Science ®Google Scholar
• Reddy VS, Sethi S, Agrawal P, et al. Ischemia modified albumin (IMA) and albumin adjusted-IMA (AAIMA) as biomarkers for diabetic retinopathy. Nep J Oph 2015;7:117–23.
   PubMed Web of Science ®Google Scholar
• Beyazit F, Yilmaz N, Balci O, et al. Evaluation of oxidative stress in women with polycystic ovarian syndrome as represented by serum ischemia modified albumin and its correlation with testosterone and insulin resistance. Intern Med 2016;55:2359–64.
   PubMed Web of Science ®Google Scholar
• Caglar GS, Oztas E, Karadag D, et al. Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance. Fertil Steril 2011;95:310–13.
   PubMed Web of Science ®Google Scholar
• Cakir E, Ozbek M, Ozkaya E, et al. Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients. J Endocrinol Invest 2011;34:e178–82.
   PubMed Web of Science ®Google Scholar
• Duzguner INB, Yasemin T, Gamze SC, et al. The impact of follicular fluid ischemia-modified albumin levels on ICSI outcomes ın PCOS patients. J Pregnancy Reprod 2017;1:5.
   Google Scholar
• Guven S, Karahan SC, Bayram C, et al. Elevated concentrations of serum ischaemia-modified albumin in PCOS, a novel ischaemia marker of coronary artery disease. Reprod Biomed Online 2009;19:493–500.
   PubMed Web of Science ®Google Scholar
• Inal ZO, Sami E, Yavuz G, et al. The impact of serum adropin and ischemia modified albumin levels based on BMI in PCOS. Endokrynologia Polska 2018;69:135–41.
   PubMed Web of Science ®Google Scholar
• Kosem A, Tokmak A, Topcuoglu C, Turhan T. Serum ischemia modified albumin levels in non-obese young women with polycystic ovary syndrome. FEBS congress 2016; ST-Mis-023.
   Google Scholar
• Ozturk M, Keskin U, Ozturk O, et al. Are serum gamma-glutamyl transferase, high-sensitivity C-reactive protein, and ischaemia-modified albumin useful in diagnosing PCOS? J Obstet Gynaecol 2016;36:929–34.
   PubMedGoogle Scholar
• Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 2016; DOI: 10.1177/0962280216669183.
   Web of Science ®Google Scholar
• Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014;14:135.
   PubMed Web of Science ®Google Scholar
• Murri M, Luque-Ramírez M, Insenser M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 2013;19:268–88.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 2004;81:19–25.
   Web of Science ®Google Scholar
• Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000;19:311–15.
   PubMed Web of Science ®Google Scholar
• Sathyapalan T, Atkin SL. Recent advances in cardiovascular aspects of polycystic ovary syndrome. Eur J Endocrinol 2012;166:575–83.
   PubMed Web of Science ®Google Scholar
• Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007;370:685–97.
   PubMed Web of Science ®Google Scholar
• Giallauria F, Orio F, Palomba S, et al. Cardiovascular risk in women with polycystic ovary syndrome. J Cardiovasc Med (Hagerstown) 2008;9:987–92.
   PubMed Web of Science ®Google Scholar
• Gaze DC. Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia. Drug Metab Pharmacokinet 2009;24:333–41.
   PubMed Web of Science ®Google Scholar